At-risk 12 to 15-year-olds eligible for booster doses from Monday
The NHS is rolling out Covid boosters to those in the age group who are clinically vulnerable or live with someone who is immunosuppressed.
Clinically vulnerable 12 to 15-years-olds who are most at risk from coronavirus will be able to get their Covid booster jab from Monday.
Around 500 children will be eligible, including those receiving chemotherapy or radiotherapy, those with leukaemia, diabetes, chronic diseases or severe mental illness, and those who live with someone who is immunosuppressed.
They are entitled to their booster three months after their two primary vaccine doses, while severely immunosuppressed children can get their booster after a third primary dose.
GPs have already begun sending out invites to the parents or guardians of eligible children, encouraging them to secure an appointment through a local booking system.
The youngsters can also get the jab at hospital hubs, via their GP, through a home visit or by going to a walk-in vaccination site – as long as they show their NHS invitation letter.
Parents are asked to accompany their children.
“I am delighted that we can kick off this stage of the rollout with the most at-risk children eligible from today, and we look forward to encouraging many more to come forward in the coming days and weeks.
“As soon as you receive the invitation from your local NHS team or GP, please do take up the offer and bring your child forward for their all-important protection as soon as you can.”
Recent data from the UK Health Security Agency (UKHSA) showed that two doses of the vaccine are not enough to stop people becoming unwell from Omicron, but a booster significantly increases protection against the variant.
From Monday, 16 and 17-year-olds will also be eligible for their top-up dose.
Since the vaccination campaign opened to all 12 to 15-year-olds in September, more than 1.4 million in that age group have had their first dose. The cohort is also eligible for a second dose 12 weeks after their first.
In total, more than 114 million doses have been delivered in England since December 2020, including more than 30 million top-up doses.
